15 Minute News 15 Minute Fun
Follow Us
Sign In
Sign In
to Comment, Vote &
Create Storyboards.
A phase 1 clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers. The trial looked at AZD1775, an inhibitor designed to block an enzyme called Wee1, which plays a role in DNA damage repair.
0
views
0
likes
0
dislikes


Storyboard
Print


Share this Article



Similar Articles
Comments


Please Sign In to comment


##username##
##datetime##
##comment##
##commentlikeno##Likes
##commentdislikeno##Dislikes




Terms & Conditions | About | Enquiries | Advertise